Vir Biotechnology (VIR) Return on Sales (2018 - 2025)
Historic Return on Sales for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to 679.75%.
- Vir Biotechnology's Return on Sales fell 5899600.0% to 679.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 29.64%, marking a year-over-year decrease of 228500.0%. This contributed to the annual value of 7.03% for FY2024, which is 1000.0% up from last year.
- According to the latest figures from Q3 2025, Vir Biotechnology's Return on Sales is 679.75%, which was down 5899600.0% from 91.4% recorded in Q2 2025.
- In the past 5 years, Vir Biotechnology's Return on Sales registered a high of 1.07% during Q3 2021, and its lowest value of 679.75% during Q3 2025.
- Its 5-year average for Return on Sales is 61.28%, with a median of 6.91% in 2023.
- Per our database at Business Quant, Vir Biotechnology's Return on Sales soared by 859000bps in 2022 and then crashed by -5899600bps in 2025.
- Over the past 5 years, Vir Biotechnology's Return on Sales (Quarter) stood at 0.65% in 2021, then crashed by -418bps to 2.06% in 2022, then crashed by -236bps to 6.91% in 2023, then fell by -22bps to 8.45% in 2024, then plummeted by -7942bps to 679.75% in 2025.
- Its last three reported values are 679.75% in Q3 2025, 91.4% for Q2 2025, and 39.9% during Q1 2025.